Pharmaceuticals news FT.com

A biotech M&A revival is in the pipeline

Acquisitions hold the cure for pharma companies’ chronic patent cliff problem

Apr 2, 2025 - 05:05
 0
A biotech M&A revival is in the pipeline
Acquisitions hold the cure for pharma companies’ chronic patent cliff problem
Read More

Tags:

Previous Article

EXCLUSIVE: Step Inside Acqua di Parma’s New Store in Paris

Next Article

Rwanda plans to raise contribution of garment units in domestic market

Related Posts

Investors lose their appetite for the obesity trade

Investors lose their appetite for the obesity trade

Feb 9, 2025  0

Eli Lilly expects to beat profit forecasts on obesity drug demand

Eli Lilly expects to beat profit forecasts on obesity d...

Feb 9, 2025  0

‘Road map’ outlining how cancers spread offers hope for new treatments

‘Road map’ outlining how cancers spread offers hope for...

Feb 14, 2025  0